Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries.
Adult
Developing Countries
/ statistics & numerical data
Female
Fetus
/ diagnostic imaging
Guatemala
/ epidemiology
Humans
Infant
Infant Mortality
/ trends
Infant, Low Birth Weight
Infant, Newborn
Male
Oligohydramnios
/ diagnostic imaging
Pakistan
/ epidemiology
Pregnancy
Pregnancy Outcome
/ epidemiology
Prenatal Care
/ statistics & numerical data
Prospective Studies
Ultrasonography, Prenatal
Young Adult
Zambia
/ epidemiology
Low and middle-income countries
Oligohydramnios
Pregnancy outcomes
Ultrasound
Journal
Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380
Informations de publication
Date de publication:
30 Jan 2020
30 Jan 2020
Historique:
received:
16
02
2019
accepted:
06
01
2020
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
20
11
2020
Statut:
epublish
Résumé
Oligohydramnios is a condition of abnormally low amniotic fluid volume that has been associated with poor pregnancy outcomes. To date, the prevalence of this condition and its outcomes has not been well described in low and low-middle income countries (LMIC) where ultrasound use to diagnose this condition in pregnancy is limited. As part of a prospective trial of ultrasound at antenatal care in LMICs, we sought to evaluate the incidence of and the adverse maternal, fetal and neonatal outcomes associated with oligohydramnios. We included data in this report from all pregnant women in community settings in Guatemala, Pakistan, Zambia and the Democratic Republic of Congo (DRC) who received a third trimester ultrasound as part of the First Look Study, a randomized trial to assess the value of ultrasound at antenatal care. Using these data, we conducted a planned secondary analysis to compare pregnancy outcomes of women with to those without oligohydramnios. Oligohydramnios was defined as measurement of an Amniotic Fluid Index less than 5 cm in at least one ultrasound in the third trimester. The outcomes assessed included maternal morbidity and fetal and neonatal mortality, preterm birth and low-birthweight. We used pairwise site comparisons with Tukey-Kramer adjustment and multivariable logistic models using general estimating equations to account for the correlation of outcomes within cluster. Of 12,940 women enrolled in the clusters in Guatemala, Pakistan, Zambia and the DRC in the First Look Study who had a third trimester ultrasound examination, 87 women were diagnosed with oligohydramnios, equivalent to 0.7% of those studied. Prevalence of detected oligohydramnios varied among study sites; from the lowest of 0.2% in Zambia and the DRC to the highest of 1.5% in Pakistan. Women diagnosed with oligohydramnios had higher rates of hemorrhage, fetal malposition, and cesarean delivery than women without oligohydramnios. We also found unfavorable fetal and neonatal outcomes associated with oligohydramnios including stillbirths (OR 5.16, 95%CI 2.07, 12.85), neonatal deaths < 28 days (OR 3.18, 95% CI 1.18, 8.57), low birth weight (OR 2.10, 95% CI 1.44, 3.07) and preterm births (OR 2.73, 95%CI 1.76, 4.23). The mean birth weight was 162 g less (95% CI -288.6, - 35.9) with oligohydramnios. Oligohydramnos was associated with worse neonatal, fetal and maternal outcomes in LMIC. Further research is needed to assess effective interventions to diagnose and ultimately to reduce poor outcomes in these settings. NCT01990625.
Sections du résumé
BACKGROUND
BACKGROUND
Oligohydramnios is a condition of abnormally low amniotic fluid volume that has been associated with poor pregnancy outcomes. To date, the prevalence of this condition and its outcomes has not been well described in low and low-middle income countries (LMIC) where ultrasound use to diagnose this condition in pregnancy is limited. As part of a prospective trial of ultrasound at antenatal care in LMICs, we sought to evaluate the incidence of and the adverse maternal, fetal and neonatal outcomes associated with oligohydramnios.
METHODS
METHODS
We included data in this report from all pregnant women in community settings in Guatemala, Pakistan, Zambia and the Democratic Republic of Congo (DRC) who received a third trimester ultrasound as part of the First Look Study, a randomized trial to assess the value of ultrasound at antenatal care. Using these data, we conducted a planned secondary analysis to compare pregnancy outcomes of women with to those without oligohydramnios. Oligohydramnios was defined as measurement of an Amniotic Fluid Index less than 5 cm in at least one ultrasound in the third trimester. The outcomes assessed included maternal morbidity and fetal and neonatal mortality, preterm birth and low-birthweight. We used pairwise site comparisons with Tukey-Kramer adjustment and multivariable logistic models using general estimating equations to account for the correlation of outcomes within cluster.
RESULTS
RESULTS
Of 12,940 women enrolled in the clusters in Guatemala, Pakistan, Zambia and the DRC in the First Look Study who had a third trimester ultrasound examination, 87 women were diagnosed with oligohydramnios, equivalent to 0.7% of those studied. Prevalence of detected oligohydramnios varied among study sites; from the lowest of 0.2% in Zambia and the DRC to the highest of 1.5% in Pakistan. Women diagnosed with oligohydramnios had higher rates of hemorrhage, fetal malposition, and cesarean delivery than women without oligohydramnios. We also found unfavorable fetal and neonatal outcomes associated with oligohydramnios including stillbirths (OR 5.16, 95%CI 2.07, 12.85), neonatal deaths < 28 days (OR 3.18, 95% CI 1.18, 8.57), low birth weight (OR 2.10, 95% CI 1.44, 3.07) and preterm births (OR 2.73, 95%CI 1.76, 4.23). The mean birth weight was 162 g less (95% CI -288.6, - 35.9) with oligohydramnios.
CONCLUSIONS
CONCLUSIONS
Oligohydramnos was associated with worse neonatal, fetal and maternal outcomes in LMIC. Further research is needed to assess effective interventions to diagnose and ultimately to reduce poor outcomes in these settings.
TRIAL REGISTRATION
BACKGROUND
NCT01990625.
Identifiants
pubmed: 32000798
doi: 10.1186/s12978-020-0854-y
pii: 10.1186/s12978-020-0854-y
pmc: PMC6993413
doi:
Banques de données
ClinicalTrials.gov
['NCT01990625']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
19Subventions
Organisme : NICHD NIH HHS
ID : UG1 HD076461
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD078438
Pays : United States
Organisme : Bill and Melinda Gates Foundation
ID : OPP1056057
Organisme : NICHD NIH HHS
ID : UG1 HD076465
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD078438
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD076474
Pays : United States
Références
J Coll Physicians Surg Pak. 2007 Jun;17(6):336-9
pubmed: 17623581
Curr Probl Diagn Radiol. 2017 May - Jun;46(3):210-215
pubmed: 28057388
J Perinat Med. 2018 Oct 25;46(8):948-950
pubmed: 29924737
Ultrasound Obstet Gynecol. 2017 Apr;49(4):442-449
pubmed: 27062200
J Matern Fetal Neonatal Med. 2011 Mar;24(3):453-7
pubmed: 20608800
Ultrasound Q. 2014 Dec;30(4):262-6
pubmed: 25415862
PLoS One. 2015 Dec 11;10(12):e0144334
pubmed: 26658482
J Matern Fetal Neonatal Med. 2004 Apr;15(4):233-6
pubmed: 15280130
Reprod Health. 2015;12 Suppl 2:S1
pubmed: 26063166
Glob Health Sci Pract. 2016 Dec 28;4(4):675-683
pubmed: 28031304
Clin Obstet Gynecol. 1997 Jun;40(2):280-9
pubmed: 9199840
J Perinatol. 2002 Jun;22(4):282-5
pubmed: 12032790
Am J Obstet Gynecol. 2011 Sep;205(3):241.e1-6
pubmed: 22071052
BMC Pregnancy Childbirth. 2014 Feb 17;14:73
pubmed: 24533878
BJOG. 2018 Nov;125(12):1591-1599
pubmed: 29782696
BMC Pregnancy Childbirth. 2009 May 07;9 Suppl 1:S5
pubmed: 19426468
Int J Gynaecol Obstet. 2002 Jan;76(1):15-21
pubmed: 11818089